Clin2
NCT07265076Worth exploringNot yet recruiting

Omega-6 fats and liver cancer risk

Carcinoma, Hpatocellular

Part of Cancer clinical trials.

This study looks at whether omega-6 fatty acids (a type of fat found in some foods and supplements) play a role in the development of liver cancer. It compares people with liver cancer, people with liver cirrhosis (scarring of the liver), and healthy volunteers to find possible links.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 50 years
Study type
Observational

Who can take part

  • You are 18 years old or older.
  • You either have liver cancer (hepatocellular carcinoma), have liver cirrhosis but no cancer, or are a healthy volunteer without liver disease.
  • You are not currently taking omega-3 or omega-6 supplements.
  • You do not have another type of cancer or a chronic inflammatory disease (other than cirrhosis or liver cancer).
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06523179Recruiting
Liver cancer risk study for people with fatty liver disease

This study looks at your risk of developing liver cancer (hepatocellular carcinoma) if you have a liver condition such as NAFLD or a related disease. It aims to improve how doctors predict who might be at higher risk, so they can offer better monitoring and care.

Milan, Milano
NCT06623474Recruiting
Fat markers in blood for liver cancer study

This study is for people having liver cancer surgery. It will look at certain fats in your blood to see if they can help doctors understand and track liver cancer better.

Guangzhou, Guangdong
NCT07119957Recruiting
Liver cancer study: chemical and social risk factors

This study looks at how chemicals in our environment and life stress might be linked to liver cancer. It is for people with fatty liver disease caused by metabolism or alcohol, who are having a liver biopsy.

Angers
NCT06864221Recruiting
How fat molecules in blood affect liver cancer radiotherapy

This study looks at whether certain fats in your blood can help predict how well radiotherapy works for liver cancer. If you are getting radiation for liver cancer, your blood samples may help doctors learn more about your treatment response.

Guangzhou, Guangdong
NCT07272200Recruiting
Genes and alcohol in liver cancer: a study

This study looks at how your genes and alcohol use together affect the risk of liver cancer. It may help find ways to prevent cancer in people with fatty liver disease or moderate alcohol intake.

Milan, Milano
NCT07160946Recruiting
Liver cancer risk check for people with hepatitis B

This study looks at your risk of developing liver cancer if you have hepatitis B. It uses your medical history and test results to give you a better idea of your risk and help guide next steps.

Guangzhou, Guangdong

Hear when a new Carcinoma, Hpatocellular trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.